欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2025, Vol. 30 ›› Issue (6): 750-762.doi: 10.12092/j.issn.1009-2501.2025.06.004

• 基础研究 • 上一篇    下一篇

黄芪三七合剂抑制lncRNA Gm51500/Adam12轴改善CKD肾脏纤维化

林婧怡1,韩壤乐1,徐玲慧1,谭睿陟1,粟宏伟2,王丽1   

  1. 1西南医科大学附属中医医院中西医结合研究中心,泸州  646000,四川;2西南医科大学附属中医医院泌尿外科,泸州  646000,四川

  • 收稿日期:2024-06-19 修回日期:2024-08-08 出版日期:2025-06-26 发布日期:2025-06-09
  • 通讯作者: 王丽,女,教授,博士生导师,研究方向:中医药调控免疫炎症与肾脏纤维化。 E-mail: wangli120@swmu.edu.cn
  • 作者简介:林婧怡,女,硕士研究生,研究方向:中医药调控免疫炎症与肾脏纤维化。 E-mail: llinjingyi@163.com
  • 基金资助:
    四川省科技厅项目(2022YFS0621,2025ZNSFSC0617)

Huangqi sanqi mixture inhibits lncRNA Gm51500/Adam12 axis to improve renal fibrosis in CKD

LIN Jingyi1, HAN Rangyue1, XU Linghui1, TAN Ruizhi1, SU Hongwei2, WANG Li1   

  1. 1Research Center of Intergated Traditional Chinese and Western Medicine, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou 646000, Sichuan, China; 2Department of Urology, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou 646000, Sichuan, China
  • Received:2024-06-19 Revised:2024-08-08 Online:2025-06-26 Published:2025-06-09

摘要:

目的:通过对单侧输尿管结扎(UUO)小鼠组及黄芪三七合剂干预组的肾脏进行转录组测序,利用生物信息学验证差异显著的lncRNA,探究黄芪三七合剂对改善肾脏纤维化的潜在机制。方法:将24只C57小鼠分为假手术组、肾脏纤维化组、黄芪三七合剂干预组(3.944 g/kg)及厄贝沙坦阳性对照干预组,每组6只小鼠。采用单侧输尿管结扎建立肾纤维化小鼠模型。术后予以灌胃给药,连续给药7 d后处死动物并采集标本。通过HE、Masson染色分析黄芪三七合剂对肾纤维化病理损伤的改变,同时通过Western blot、免疫组化检测各组肾脏组织Fn、α-SMA的蛋白水平,评估黄芪三七合剂对肾纤维化的缓解作用。随后通过转录组测序,获取了lncRNA的表达信息,在分析数据质量、GO富集和差异lncRNA后进行Quantitative Real-time PCR(qPCR)验证,根据测序所获得的差异lncRNA及靶点分析结果,在体外过表达lncRNA Gm51500/Adam12,用免疫组化及免疫荧光染色和qPCR验证的方式,研究其在黄芪三七合剂保护肾脏纤维化中的作用机制。结果:与模型组比较,黄芪三七合剂干预组小鼠的肾脏纤维化明显减轻,其肾脏组织中α-SMA、Fn的蛋白水平及lncRNA的表达量均显著下调(P<0.000 1)。筛选并验证3个lncRNA在模型组增加且黄芪三七合剂干预后显著降低,分别为lncRNA Gm29994、Gm51500及Gm35391。靶点分析显示lncRNA Gm51500与Adam12的关系最显著。动物实验结果表明,Adam12在UUO小鼠肾脏中高表达,黄芪三七合剂干预后被显著抑制。随后的细胞实验证实,过表达lncRNA Gm51500可上调TGF-β诱导的肾小管细胞纤维化以及Adam12的表达。细胞回复实验明确了过表达Adam12逆转了黄芪三七合剂对肾小管细胞损伤和纤维化的抑制作用。结论:黄芪三七合剂可以改善肾脏纤维化,基于转录组测序发现lncRNA Gm51500/Adam12轴可能是黄芪三七合剂改善肾脏纤维化的潜在靶点。

关键词: 黄芪三七合剂, 肾脏纤维化, lncRNA, 高通量测序

Abstract:

AIM: To explore the potential of Huangqi sanqi mixture (AP) in improving renal fibrosis by performing transcriptome sequencing of the kidneys of the unilateral ureteral ligation mouse group and the Huangqi sanqi mixture intervention group, and using bioinformatics to verify the signitficantly different IncRNAs mechanism. METHODS: Twenty-four C57 mice were divided into sham operation group, renal fibrosis group, Huangqi sanqi mixture intervention group (3.944 g/kg) and irbesartan positive control intervention group, with 6 mice in each group. A mouse model of renal fibrosis was established by unilateral ureteral ligation (UUO). The animals were given intragastric administration after operation, and the animals were sacrificed and the specimens were collected after seven consecutive days of administration. The changes of Huangqi sanqi mixture on renal fibrosis pathological damage were analyzed by HE and Masson staining, and the protein levels of Fn and α-SMA in renal tissue of each group were detected by Western blot and immunohistochemistry to evaluate the alleviating effect of Huangqi sanqi mixture on renal fibrosis. Subsequently, lncRNA expression information was obtained by transcriptome sequencing, and Quantitative Real-time PCR (qPCR) was performed after data quality, GO enrichment and differential lncRNA were analyzed. According to the differential lncRNA and target analysis results obtained by sequencing, lncRNA Gm51500/Adam12 was overexpressed in vitro, and its mechanism in the protection of renal fibrosis by Huangqi sanqi mixture was studied by immunohistochemistry, immunofluorescence staining and qPCR verification. RESULTS: Compared with the model group, the renal fibrosis of the mice in the Huangqi sanqi mixture intervention group was significantly reduced, and the protein levels of α-SMA and Fn and the expression of IncRNA in the renal tissue were significantly down-regulated (P<0.000 1). Three lncRNAs were screened and verified to increase in the model group and significantly decrease after AP intervention, namely lncRNA Gm29994, Gm51500 and Gm35391. Target analysis showed that lncRNA Gm51500 had the most significant relationship with Adam12. The results of animal experiments showed that Adam12 was highly expressed in the kidney of UUO mice and was significantly inhibited after AP intervention. Subsequent cell experiments confirmed that overexpression of lncRNA Gm51500 could up-regulate TGF-β-induced renal tubular cell fibrosis and Adam12 expression. Cell recovery experiments confirmed that Adam12 overexpression reversed the inhibitory effect of AP on renal tubular cell injury and fibrosis. CONCLUSION: Huangqi sanqi mixture can improve renal fibrosis. Based on transcriptomic sequencing, lncRNA Gm51500/Adam12 axis may be a potential target for Huangqi sanqi mixture to improve renal fibrosis. 

Key words: Huangqi sanqi mixture, renal fibrosis, lncRNA, high-throughput sequencing

中图分类号: